CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 114,945	$ 78,708
Research and development incentive receivable	768	917
Prepaid expenses and other current assets	4,246	3,682
Total current assets	119,959	83,307
Property and equipment, net	1,788	1,237
Goodwill	27,109	27,109
Right-of-use assets	9,788	7,960
Other assets	2,391	3,258
Total assets	161,035	122,871
Current liabilities:
Accounts payable	3,091	3,144
Accrued expenses	10,706	8,018
Current portion of lease liability	875	786
Total current liabilities	14,672	11,948
Long-term debt, including accretion, net of discount	33,356	33,178
Lease liabilities	5,579	4,484
Other liabilities	491	462
Total liabilities	54,098	50,072
Commitments and contingencies (Note 9)
Redeemable common stock, 229,885 and zero issued and outstanding at March 31, 2021 and December 31, 2020, respectively (Note 11)	1,875	0
Stockholders’ equity:
Common stock, $0.001 par value, 125,000,000 shares authorized as of each of March 31, 2021 and December 31, 2020; 23,426,429 and 16,305,731 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively	24	16
Additional paid-in capital	318,008	267,077
Accumulated other comprehensive loss	(119)	(119)
Accumulated deficit	(212,851)	(194,175)
Total stockholders’ equity	105,062	72,799
Total liabilities, redeemable common stock and stockholders’ equity	$ 161,035	$ 122,871